Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Adicet Bio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- −8 vs. Q4 2024
- Shares held
- 55.9M
- −1.76M (−3.1%) vs. Q4 2024
- Total value
- $42.0M
- −$13.4M (−24.2%) vs. Q4 2024
- New holders
- 4
- 13 more added
- Sold out
- 12
- 22 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $52.8M |
| Q1 2026 | 49 | $43.7M |
| Q4 2025 | 49 | $56.6M |
| Q3 2025 | 54 | $41.6M |
| Q2 2025 | 49 | $31.5M |
| Q1 2025 | 56 | $42.0M |
| Q4 2024 | 64 | $55.4M |
| Q3 2024 | 64 | $82.3M |
| Q2 2024 | 86 | $77.4M |
| Q1 2024 | 98 | $176.6M |
| Q4 2023 | 77 | $63.0M |
| Q3 2023 | 84 | $48.9M |
| Q2 2023 | 95 | $90.4M |
| Q1 2023 | 107 | $231.3M |
| Q4 2022 | 100 | $375.7M |
| Q3 2022 | 102 | $590.7M |
| Q2 2022 | 101 | $555.9M |
| Q1 2022 | 88 | $660.4M |
| Q4 2021 | 81 | $531.2M |
| Q3 2021 | 58 | $156.1M |
| Q2 2021 | 66 | $218.1M |
| Q1 2021 | 54 | $266.3M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Thompson Investment Management, Inc. | 80 | $60 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 95 | $72 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 764 | $577 | 0.00% | +593+346.8% | Added |
| BNP Paribas Arbitrage, SA | 894 | $675 | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 900 | $680 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,170 | $883 | 0.00% | −149,315−99.2% | Reduced |
| Simplex Trading, LLC | 1,855 | $1.00K | 0.00% | −12,620−87.2% | Reduced |
| Morgan Stanley | 1,683 | $1.27K | 0.00% | −6,242−78.8% | Reduced |
| Citigroup Inc | 2,290 | $1.73K | 0.00% | +2,048+846.3% | Added |
| Group One Trading, L.P. | 6,792 | $5.13K | 0.00% | −4,408−39.4% | Reduced |
| Coldstream Capital Management Inc | 8,875 | $6.70K | 0.00% | +8,875 | New |
| Squarepoint Ops LLC | 11,567 | $8.73K | 0.00% | −172,789−93.7% | Reduced |
| Cubist Systematic Strategies, LLC | 12,398 | $9.36K | 0.00% | −118−0.9% | Reduced |
| StoneX Group Inc. | 12,448 | $9.40K | 0.00% | +12,448 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 13,473 | $10.2K | 0.00% | −26,524−66.3% | Reduced |
| Ground Swell Capital, LLC | 15,947 | $12.0K | 0.03% | +15,947 | New |
| Jane Street Group, LLC | 16,299 | $12.3K | 0.00% | +3,987+32.4% | Added |
| Caxton Corp | 17,488 | $13.2K | 0.26% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 18,288 | $13.8K | 0.00% | +18,288 | New |
| Bank of America Corp | 20,541 | $15.5K | 0.00% | −16,822−45.0% | Reduced |
| Virtu Financial LLC | 23,727 | $18.0K | 0.00% | −6,884−22.5% | Reduced |
| Charles Schwab Investment Management Inc | 30,000 | $22.6K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 34,247 | $25.9K | 0.00% | +5,338+18.5% | Added |
| Qube Research & Technologies Ltd | 53,834 | $40.6K | 0.00% | −82,273−60.4% | Reduced |
| Vontobel Holding Ltd. | 60,000 | $46.6K | 0.00% | +10,000+20.0% | Added |
| UBS Group AG | 64,039 | $48.3K | 0.00% | −139,190−68.5% | Reduced |
| Northern Trust Corp | 140,373 | $106.0K | 0.00% | +40.0% | Added |
| Dimensional Fund Advisors LP | 147,814 | $111.8K | 0.00% | 00.0% | Unchanged |
| Wealthedge Investment Advisors, LLC | 227,801 | $172.0K | 0.08% | +154,037+208.8% | Added |
| State Street Corp | 246,921 | $186.4K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 248,990 | $188.0K | 0.00% | −56,917−18.6% | Reduced |
| Stonepine Capital Management, LLC | 508,266 | $203.5K | 0.24% | −191,734−27.4% | Reduced |
| Johnson & Johnson | 364,472 | $275.2K | 0.08% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 457,722 | $345.6K | 0.00% | −19,953−4.2% | Reduced |
| Two Sigma Investments, LP | 494,978 | $373.7K | 0.00% | −208,383−29.6% | Reduced |
| D. E. Shaw & Co., Inc. | 505,469 | $381.6K | 0.00% | −341,595−40.3% | Reduced |
| DAFNA Capital Management LLC | 600,000 | $453.0K | 0.13% | 00.0% | Unchanged |
| RBF Capital, LLC | 617,319 | $466.1K | 0.03% | +16,184+2.7% | Added |
| Two Sigma Advisers, LP | 622,839 | $470.2K | 0.00% | −171,200−21.6% | Reduced |
| Alyeska Investment Group, L.P. | 655,665 | $495.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 749,067 | $565.5K | 0.00% | −62,709−7.7% | Reduced |
| Geode Capital Management, LLC | 770,703 | $582.1K | 0.00% | +3,162+0.4% | Added |
| Renaissance Technologies LLC | 810,700 | $612.1K | 0.00% | −105,800−11.5% | Reduced |
| Bridgeway Capital Management, LLC | 901,600 | $680.7K | 0.02% | −125,000−12.2% | Reduced |
| Regeneron Pharmaceuticals, Inc. | 968,183 | $731.0K | 0.06% | 00.0% | Unchanged |
| Millennium Management LLC | 1,223,869 | $924.0K | 0.00% | −590,445−32.5% | Reduced |
| Blackstone Group Inc. | 1,236,453 | $933.5K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,248,711 | $942.8K | 0.00% | +1,228,465+6,067.7% | Added |
| Acadian Asset Management LLC | 2,039,324 | $1.54M | 0.00% | +36,277+1.8% | Added |
| Aquilo Capital Management, LLC | 2,456,194 | $1.85M | 5.00% | −75,000−3.0% | Reduced |
| Carlyle Group Inc. | 2,948,718 | $2.28M | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,205,882 | $2.42M | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 3,816,556 | $2.88M | 0.00% | +63,691+1.7% | Added |
| Ra Capital Management, L.P. | 7,541,000 | $5.69M | 0.10% | 00.0% | Unchanged |
| Tang Capital Management LLC | 8,223,612 | $6.21M | 0.34% | +77,624+1.0% | Added |
| OrbiMed Advisors LLC | 11,447,140 | $8.64M | 0.21% | 00.0% | Unchanged |
| Norges Bank | 0 | $0 | 0.00% | −429,550−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −111,642−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −85,517−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −68,197−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −51,175−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −47,903−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −40,306−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −16,762−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −168−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −357−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −414−100.0% | Sold out |